Mario Anglada: Hoy Health

Story by: Jake Rivard


HEALTHCARE FOR ALL: How Mario Anglada is Pushing the Boundaries of Healthcare



THE HISPANIC COMMUNITY makes up 17% of the United States’ population and is projected to reach 30% by the end of 2030. They have larger families, suffer from higher rates of chronic health conditions, and live longer with their conditions.

Why aren’t health care companies reaching out to these communities?

That’s the question Mario Anglada, founder of Hoy Health asked himself before embarking on his journey. A seasoned veteran in the healthcare industry, Anglada spent over 23 years working with healthcare juggernauts like P&G, Johnson & Johnson, Cardinal Health, and even Univision Communications. In that time, he noticed that attention to Hispanic communities was sorely lacking. With a heart full of ambition and a mind full of ideas, Anglada set out to found Hoy Health, a Hispanic-focused healthcare platform that prioritizes access, affordability, and engagement for communities around North and South America. He wants to disrupt how primary care is delivered to underserved populations. And he is getting noticed; Hoy Health was named as one of 15 most innovative companies in 2019 by a reputable health related newsletter.

“Our goal is to be the company that addresses the needs of our community,” Anglada exclaims. Hoy Health’s focus on access, affordability, and engagement allow them to provide essential care for patients with and without health insurance. “Any group, no matter their income, can access Hoy Health’s basic services.” Patients have access to over 3,700 different medications, each prioritizing affordability above all else. In fact, their highest price point for generic medication tops off at only $40. Accessibility is a value Anglada has emphasized since Hoy Health’s first day. Hoy Health’s status as an omnichannel platform allows patients to access its services wherever and however patients need -- whether it’s by the phone, on the Internet, or even at a supermarket. All of their material is available in Spanish and English to help both bilingual and monolingual patients receive the care and support they need. “We’ve made it our goal to work hand-in-hand with patient and provider to ensure that treatment is accessible, affordable, and engaging for both parties.”



• Founder & CEO, Hoy Health

• Born & raised in Puerto Rico

• Worked alongside P&G, Johnson & Johnson, Cardinal Health, Nestle Healthcare, and Univision Communications

• 23+ years experience in healthcare


One of Hoy Health’s most innovative systems is their Chronic Condition Management. Through this program, Hoy Health partners with healthcare systems to manage chronic patients. This allows Hoy Health to provide affordable remote treatment and monitoring options to patients that may not otherwise have access to them. They work directly with healthcare providers to help them manage their patients using remote monitoring technologies that can evaluate a patient daily from their comfort of their home. This program improves health outcomes and reduces readmissions and costs for hospitals. Additionally, their CCM system offers 30-day management kits for patients that live with diabetes, asthma, and other chronic illnesses at an affordable rate. Plus, CCM doesn’t require health insurance; their kits are all valued at under $100, nearly a quarter of the cost of individual purchases. These services are available to both national and international families alike, allowing members to purchase affordable healthcare options for members in other countries.

The sky’s the limit for Mario Anglada and Hoy Health. In the future, Anglada hopes to one day provide affordable, accessible, and engaging healthcare to loved ones throughout the world. “More than anything, we want to serve as a support system to patients and providers alike.” He’s made it his goal to become the number one provider to patients without medical insurance. With the astonishing growth Hoy Health has had over the last few years, it seems more like a question of “when” than a question of “if”. +